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Function of LCRMP-1 in cancer invasion, migration, and metastasis. 
(A and B) Protein levels of LCRMP-1 and CRMP-1 in CL1-0/LCRMP-1– 
overexpressing (4 stable clones, 1003, 1004, 1014, 1015; 2 controls, 
2A2, 2A10) and CL1-5-F4/LCRMP-1–silenced (untreated [mock], oli-
gofectamine [reagent only], LCRMP-1–targeting siRNA [LCRMP-1 
silenced], or scrambled siRNA [nonsilenced]) cells were examined 
by immunoblotting. β-Actin was used as internal control. PT ratio, 
LCRMP-1 protein level normalized to that of mock. (A) Number of 
invading cells from LCRMP-1–expressing clones and (B) LCRMP-1– 
silenced cells quantified from modified Boyden chamber invasion 
assay (n = 3 experiments). (C) Effects of LCRMP-1 on cancer cell 
migration were examined by wound-healing assay in pools of stably 
transfected CL1-5/vector control, CL1-5/LCRMP-1, CL1-0/vector, CL1-0/ 
LCRMP-1, CL1-5/nonsilenced, and CL1-5/LCRMP-1 silenced cells. Per-
centages of migrated cells were quantified from pictures taken at 0 
and 12 hours after wounding (n = 6 experiments). (D–F) Effects of 
LCRMP-1 cancer metastasis in vivo examined by orthotopic implan-
tation with stable (D) A549/LCRMP-1–overexpressing (left) or A549/
LCRMP-1–silenced cells (right), and tail vein metastasis assays with 
(E) stable CL1-0/LCRMP-1–overexpressing (lines 1003 and 1015) or 
(F) CL1-5/LCRMP-1–silenced cells. Numbers of metastatic tumor nod-
ules were calculated from 10 mice per group (n = 2 experiments). His-
tology was confirmed by H&E staining (original magnification, ×100). 
(D–F) Arrowheads indicate orthotopic or metastatic lung tumors. (E) 
The black arrowhead indicates where tumor cells invade blood ves-
sels and form tumor thrombi. Error bars indicate mean ± SEM, and 
P values were calculated by 2-sided Student’s t test.
Table 1
LCRMP-1 induces regulation of lung metastasis in an orthotopic inoculation mouse modelA
Cell line Pleural tumor size (mm) No. of metastatic lung tumors
  Mean ± SD PB  Mean ± SD PB
A549/vector (n = 9) 2.22 ± 1.3  3.44 ± 2.24 
A549/LCRMP-1 (n = 8) 5.5 ± 2.07 0.003C 9.13 ± 3.0 < 0.001C
A549/nonsilenced control 4.57 ± 2.51  10.14 ± 2.61 
A549/LCRMP-1 silenced 2.44 ± 0.94 0.069D 5.25 ± 3.65 0.01D
AEach experimental group contained 10 mice. BP values were calculated using the 2-sided Student’s t test. CA549/vector versus A549/LCRMP-1 cells. 
DA549/nonsilenced control versus A549 /LCRMP-1–silenced cells.
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The LCRMP-1 N-terminal conserved region (residues 22–72) controls 












overexpressed  these constructs  in CL1-0  cells,  and stained  the 
cells with rhodamine-conjugated phalloidin. Notably, CL1-0 cells 
expressing LCRMP-1 proteins lacking residues 22–72 failed to 























LCRMP-1 induces regulation of lung metastasis in a tail vein metastasis mouse modelA
Cell line Total lung weight (mg) No. of lung metastases
 Mean ± SD PB Mean ± SD PB
CL1-0/vector (line 2A10) 0.164 ± 0.014  24.6 ± 8.33 
CL1-0/LCRMP-1 (line 1003) 0.192 ± 0.03 0.018C 72.1 ± 13.67 < 0.0001C
CL1-0/LCRMP-1 (line 1015) 0.202 ± 0.015 < 0.0001C 68.2 ± 14.97 < 0.0001C
CL1-5/nonsilenced control 0.35 ± 0.27  34.0 ± 7.95 
CL1-5/LCRMP-1 silenced 0.18 ± 0.03 0.0885D 11.7 ± 7.66 < 0.0001D
AEach experimental group contained 10 mice. BP values were calculated using the 2-sided Student’s t test. CCL1-0/vector (line 2A10) versus CL1-0 /LCRMP-1 
cells (line 1003 or 1015). DCL1-5 /nonsilenced control versus CL1-5 /LCRMP-1–silenced cells.
Figure 2
Effects of LCRMP-1 on filopodia formation. (A and B) Localization of 
(A) endogenous LCRMP-1 (green), (B) exogenous GFP-LCRMP-1 
(green), and actin (red) by immunofluorescent staining. (A) Preimmune 
serum and (B) CL1-0/CL1-5 mock were used as controls. LCRMP-1 
shares some common compartments with actin in its distribution, espe-
cially in lamellipodia and filopodia regions. Arrows indicate presence 
of LCRMP-1 in the filopodia region. (B) In addition, exogenous GFP–
LCRMP-1 promotes filopodia formation in both CL1-0 and CL1-5 cells. 
Numbers of filopodia were counted (n = 20 cells per group; original 
magnification, ×1,000 [A, top 2 and the bottom rows, and B, top and 
bottom row]; ×4,000 [A, third row, and B, middle row]). (C) Schematic 
of GFP-tagged LCRMP-1 N-terminal deletion mutants (LCRMP-1, 
LCRMP-1–P28AQ30A, LCRMP-1–R29AK31A, LCRMP-1Δ22, 
LCRMP-1Δ72, LCRMP-1Δ105, LCRMP-1Δ127, and CRMP-1; the 
double asterisks indicate the 2 mutation sites of each point mutation). 
(D) CL1-0 cells were transfected with indicated GFP-tagged LCRMP-1 
N-terminal deletion constructs and actin stained with rhodamine-con-
jugated phalloidin (red). Number of filopodia were counted (n = 20 
cells per group; original magnification, ×1,000). Data are presented as 
mean ± SEM, and P values were calculated by 2-sided Student’s t test.
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Effects of LCRMP-1 on actin dynamics. (A) Expressions of G-actin and F-actin in indicated CL1-0 stable cells (vector control, LCRMP-1, and LCRMP-1 
R29AK31A mutant), analyzed by immunofluorescence staining with FITC-conjugated DNase I (G-actin, green) and rhodamine-conjugated phalloidin 
(F-actin, red). For ratio-merge panel, blue and red indicate F-actin and G-actin, respectively. The level of F-actin relative to that of total actin was 
quantified (n = 100 cells per group; original magnification, ×400). (B) Expressions of G-actin and F-actin in indicated CL1-0 stable cells analyzed by 
immunoblotting. The protein level of F-actin relative to that of constant G-actin was quantified (n = 3 experiments). (C) F-actin reorganization exam-
ined by Dynamic NIWOP tomography in CL1-0/vector (line 2A10) and CL1-0/LCRMP-1 (lines 1003 and 1015) cells. Arrows indicate filopodia. Filopodia 
were counted every 5 minutes, and the averages over a 25-minute period were calculated from 8 random cells in each group (n = 2 experiments; 
original magnification, ×1,000). Error bars indicate mean ± SEM, and P values were calculated by 2-sided Student’s t test.
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Molecular mechanism of LCRMP-1–induced filopodia formation. (A) Effects of LCRMP-1 on Cdc42N17-induced filopodia regression. CL1-5 
cells were transfected with pcDNA3-Cdc42N17 (top) or cotransfected with pcDNA3-Cdc42N17 and pCMV-Tag 2A (middle) or pCMV-Tag 
2A-LCRMP-1 (bottom). Transfected cells were then stained with anti-Myc antibody (Cdc42N17, green) and rhodamine-conjugated phalloidin 
(actin, red). Arrow and arrowhead indicate cells with and without Cdc42N17 transfectants, respectively. The numbers of filopodia per cell were 
calculated from 20 cells in each group (original magnification, ×1,000). (B) Lysates from CL1-0/LCRMP-1 (lines 1003, 1004, 1014, and 1015) 
and CL1-0/vector (line 2A2) cells were immunoprecipitated with anti-Flag antibody and immunoblotted for LCRMP-1 and β-actin. (C) Actin-
nucleation proteins, N-WASP, WASP, WAVE, and p34, were analyzed by immunoblotting in indicated cell lines. β-Actin was used as internal 
control. (D) Flag-tagged LCRMP-1 binds to WAVE-1. Lysates of CL1-0/LCRMP-1 (lines 1004 and 1015) and CL1-0/vector cells (lines 2A2 and 
2A10) were examined for presence of WAVE-1 (input) and WAVE-1 coprecipitated with Flag-tagged LCRMP-1 (IP: Flag) by immunoblotting 
with anti–WAVE-1 antibody (n = 3 experiments). (E) Endogenous LCRMP-1 interacts with WAVE-1. Total cell lysates (15 mg) from CL1-5 cells 
were immunoprecipitated with anti–LCRMP-1 (C2) antibody and analyzed by immunoblotting using anti–WAVE-1 and anti–LCRMP-1 (C2) 
antibodies (n = 3 experiments). Error bars indicate mean ± SEM, and P values were calculated by 2-sided Student’s t test.
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WAVE-1 is involved in LCRMP-1–induced cancer metastasis. (A) In vitro effects of siRNA-mediated silencing of WAVE-1 in CL1-0/LCRMP-1 cells (line 
1003). Cells were analyzed for WAVE-1 protein expression by immunoblotting (right bottom) and examined for invasive ability by modified Boyden 
chamber invasion assay (right top) and filopodia formation by staining with rhodamine-conjugated phalloidin (left; original magnification, ×1,000). 
Percentage of cells with filopodia and number of filopodia per cell were counted (n = 100 cells per group). (B) In vivo effects of WAVE-1 knockdown 
in CL1-0/LCRMP-1 cells (line 1003). Mice that were tail vein injected with CL1-0/LCRMP-1/shWAVE-1 cells developed fewer pulmonary nodules than 
those injected with CL1-0/LCRMP-1/shLacZ cells (10 mice per group; n = 2 experiments). (C) pEGFP–WAVE-1 plasmids were transfected into CL1-5/ 
LCRMP-1–silenced and CL1-5/nonsilenced cells, and then the GFP-WAVE-1 fusion proteins of each group were immunoprecipitated by anti-GFP 
antibody to examine their ability to promote actin polymerization (Actin Polymerization Biochem Kit; left; n = 2 experiments). Slopes of regression 
curves were calculated. Error bars indicate mean ± SEM, and P values were calculated by 2-sided Student’s t test.
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Silencing LCRMP-1 protein expression decreases the activity of 











The expression levels of LCRMP-1 and CRMP-1 control cancer cell 
invasion and filopodia formation. Since we previously showed that 
CRMP-1 acts as an invasion suppressor (5, 16), and the above-












































































High-level LCRMP-1 and low-level CRMP-1 protein expressions are asso-
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Reciprocal regulation of cancer invasion by LCRMP-1 and CRMP-1. 
(A) Less-invasive CL1-0 cells, which typically express endogenous 
CRMP-1 but not LCRMP-1, were transfected with different amounts 
of pCMV-Tag 2A–LCRMP-1. Protein levels were confirmed by immu-
noblotting. Equal amounts of pEGFP were cotransfected into the cells 
as a control of transfection efficiency. Percentage of GFP-transfected 
cells was quantified from immunofluorescence. Invasiveness was 
measured by modified Boyden chamber invasion assay (n = 3) (left). 
The identical experiment, except for plasmid transfected (pCMV-Tag 
2A-CRMP-1), performed in highly invasive CL1-5 cells, which endog-
enously express LCRMP-1 but not CRMP-1 (right). (B) Effects of 
LCRMP-1 and CRMP-1 on morphology in CL1-0 or CL1-5. Cells were 
transfected with pEGFP, pEGFP-LCRMP-1, or pEGFP-CRMP-1. Actin 
was visualized with rhodamine-conjugated phalloidin. Number of filo-
podia per cell was calculated (n = 20 cells per group). (C) pEGFP-
LCRMP-1 or pEGFP were cotransfected with pDsRed-CRMP-1 into 
CL1-0 cells to detect localization of exogenous LCRMP-1 and CRMP-1 
in interphase, metaphase, and telophase (n = 20 cells per group). 
Arrowheads indicate the place in which only GFP-LCRMP-1 was pres-
ent. (D and E) Lysates of CL1-0 cells cotransfected with (D) Flag-tagged 
LCRMP-1 and Myc-tagged CRMP-1 and lysates of (E) H522 cells 
(15 mg) were immunoprecipitated for (D) Flag-tagged LCRMP-1 and 
(E) endogenous LCRMP-1. Presence of (D) exogenous or (E) endoge-
nous LCRMP-1 and CRMP-1 was analyzed by immunoblotting. Arrows 
indicate CRMP-1 and LCRMP-1 proteins (numbers indicate the kDa 
of each examined protein; “#16-2” refers to the clone number of anti–
CRMP-1 antibody). (F) HA-tagged CRMP-1 proteins were produced by 
in vitro transcription/translation and pulled down with GST–LCRMP-1 
proteins. Data are presented as mean ± SEM, and P values were cal-
culated by 2-sided Student’s t test (n = 3 experiments). Original mag-
nification, ×1,000 (B and C); ×4,000 (C, insets).
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Figure 7
CRMP-1 inhibits the binding between LCRMP-1 and WAVE-1 and further affects the function of LCRMP-1 on filopodia formation and invasion. 
(A) Lysates of CL1-0/vector, CL1-0/CRMP-1, and CL1-0/LCRMP-1 cells were examined for the presence of WAVE-1 and Flag-tagged LCRMP-1 
or CRMP-1 (left) and WAVE-1 coprecipitated with Flag-tagged LCRMP-1 or CRMP-1 (right) by immunoblotting using anti–WAVE-1 or anti-
Flag antibodies (n = 3 experiments). (B) A lentivirus infection-based system was used to express different amounts of HA-tagged CRMP-1 
in CL1-0/LCRMP-1 cells (line 1003). Cell lysates were immunoprecipitated with anti-Flag antibody, and binding of WAVE-1 and HA-CRMP-1 
was examined by immunoblotting. Amounts of coprecipitated WAVE-1 normalized to the level of precipitated Flag–LCRMP-1 were quantified 
(n = 3 experiments). (C) Different amounts of HA-tagged CRMP-1 were expressed in CL1-0/LCRMP-1 cells by lentiviral infection, and actin 
was visualized by staining with rhodamine-conjugated phalloidin (left; original magnification, ×600). Number of filopodia per cell was counted 
(n = 20 cells per group). (D) In vitro–modified Boyden chamber invasion assay was used to compare the number of invading cells between control 
(Neo, MOI 1 and 4) and HA-CRMP-1–expressing clones (n = 3 experiments). Data are shown as mean ± SEM, and P value was calculated by 
2-sided Student’s t test.
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Figure 8
Kaplan-Meier survival plots for patients with NSCLC grouped by LCRMP-1 and CRMP-1 protein expression levels. (A) Protein expression of CRMP-1 
and LCRMP-1 was examined by immunohistochemical staining in serial dissections of primary tumor specimens from 142 patients with NSCLC who 
underwent surgical resections. Results from 3 patients are shown (original magnification, ×100). (B and C) Patients were designated as having high 
LCRMP-1 or CRMP-1 expression if more than 50% of the neoplastic cells in their tumor sections were immunoreactive and as having low LCRMP-1 
or CRMP-1 expression if fewer than 50% were immunoreactive. The results shown reflect Kaplan–Meier estimates of (B) overall survival and (C) dis-
ease-free survival in the 142 patients with NSCLC, according to their expression levels of LCRMP-1, CRMP-1, or both. P values were obtained from 
2-sided log-rank tests. (D) Proposed model of the actin/filopodia formation pathway. Cells typically form filopodia through Cdc42/WASPs/actin pathway. 
Cdc42 activates WASP nucleation proteins, forms Arp2/3 complex, and promotes actin polymerization, filopodia formation, cell migration, and inva-
sion. In some cancer cells, filopodia formation can be regulated through CRMP-1/LCRMP-1/WAVE-1/actin pathway. LCRMP-1 could form a complex 
with WAVE-1 and actin and potentially act via Arp2/3 complex to promote actin polymerization, filopodia formation, and cell migration, invasion, and 
metastasis. Furthermore, CRMP-1 could heterodimerize with LCRMP-1 and inhibit the binding of LCRMP-1 to WAVE-1.
Downloaded from http://www.jci.org on July  7, 2016.   http://dx.doi.org/10.1172/JCI42975
research article
























































































HRs for death (from any cause) among patients with NSCLC, 
according to multivariable Cox regression analysisA
Variable HR (95% CI) P
Age 0.96 (0.92 to 1.00) 0.035
Histological type 0.07 (0.02 to 0.25) < 0.001
Stage 1.92 (1.23 to 2.99) 0.004
CRMP-1 expression 0.15 (0.06 to 0.41) < 0.001
LCRMP-1 expression 17.56 (5.49 to 56.17) < 0.001
AStepwise selection was used to choose the optimal multivariable Cox 
proportional-hazards regression model. CRMP-1 and LCRMP-1 expres-
sion was designated as high or low using 50% percent cell positivity 
as the cut-off point and adjusted by histological type (squamous cell 
carcinoma as the referent vs. adenocarcinoma) and stage (stage I as 
the referent vs. stage II vs. stage III). P values (2 sided) were calculated 
using a c2 test.
Table 4
HRs for metastasis among patients with NSCLC, according to 
multivariable Cox regression analysisA
Variable HR (95% CI) P
CRMP-1 expression 0.25 (0.12 to 0.53) 0.0003
LCRMP-1 expression 2.8 (1.37 to 5.75) 0.0049
AStepwise selection was used to choose the optimal multivariable Cox 
proportional-hazards regression model. CRMP-1 and LCRMP-1 expres-
sion was designated as high or low using 50% percent cell positivity 
as the cut-off point and adjusted by histological type (squamous cell 
carcinoma as the referent vs. adenocarcinoma) and stage (stage I as 
the referent vs. stage II vs. stage III). P values (2 sided) were calculated 
using a c2 test.
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Immunohistochemical analysis of LCRMP-1 and CRMP-1 expression in tumor 
















Statistics.  The  correlations  between  various  clinical  and pathologi-
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